Sign in
Active, not recruitingNo phase

Transorbital Ultrasound and Other Markers for Prognosis Prediction After Cardiac Arrest

Key facts

Who runs it
University Hospital Pilsen
Where
Czechia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
80 people, planned
Started
4 Jan 2021
Expected to end
1 Dec 2026
Type of study
Observational
Treatments tested
  • Optic nerve sheath diameter measured by transorbital ultrasound
Record updated
9 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • age of 18 years or older
  • out of hospital cardiac arrest of non-traumatic cause with CPR and subsequent ROSC
  • Glasgow coma scale (GCS) ≤ 7 or sedation 30 minutes after ROSC achievment

Who cannot take part

  • refractory cardiac arrest
  • active intracranial bleeding
  • haemorrhagic stroke and/or subarachnoid haemorrhage in the last 3 months
  • active neuroendocrine tumor, small cell lung cancer, non-small cell lung
  • CPC 3-5 before cardiac arrest
  • unavailable first measurment of the optic nerve sheath diameter (ONSD) measured by transorbital ultrasonography 24±6 hours after ROSC achievement
  • craniocerebral injury
  • intracranial tumor
  • facial trauma affecting the eye area
  • sclerosis multiplex and/or optic neuritis of other etiology

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In sudden cardiac arrest patients with return of spontaneous circulation, brain damage is one of the main determinants of short-term mortality and poor prognosis (CPC 3-5). It is important to properly select group of patients in whom treatment is futile. According to current guidelines, multimodal approach is recommended. Optic nerve sheath diameter measured by ultrasound is non-invasive, fast, low-cost and readily available bed-side method, but evidence for its use as neuroprognostication modality is limited to only few small studies. The aim of this study is to evaluate validity of ONSD as neuroprognostication method at larger cohort of patients, compare it with other established methods and compare ultrasound and CT measurement of ONSD.

Treatments tested

  • Optic nerve sheath diameter measured by transorbital ultrasound

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Transorbital Ultrasound and Other Markers for Prognosis Prediction After Cardiac Arrest (TOMCAT)
Record updated
9 April 2026